ArticleBreast cancer research and treatment2026

Metastatic metaplastic triple negative breast cancer response to sacituzumab govitecan and biomarker targetability.

Shivahamy Maheswaran et al.PubMed ↗Publisher ↗

No numbers read from the abstract.